Concepedia
Statistics
Publications
15
Citations
950
H-Index
Active since
1991
Affiliations
University of Arizona(Current)
Arizona Science Center
University of Illinois Chicago, Rockford campus
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Thomas H. Burkey is an author at University of Arizona specializing in pharmacology, medicine, and neuropharmacology.
Publications per year
1991–2004
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
Robert S Landsman, Thomas H. Burkey, Paul Consroe et al. · European Journal of Pharmacology · 1997 · 265 citations
Medicine, Neuroscience, Pharmacology +8
6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist
David F. Woodward, David J. Pepperl, Thomas H. Burkey et al. · Biochemical Pharmacology · 1995 · 106 citations
Medicine, Medicinal Chemistry, Pharmacology +4
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain
Thomas H. Burkey, Raymond M. Quock, Paul Consroe et al. · European Journal of Pharmacology · 1997 · 93 citations
Medicine, Neuroscience, Pharmacology +9
Tumor necrosis factor α and interleukin-1β stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells
Jill C. Fehrenbacher, Thomas H. Burkey, Grant D. Nicol et al. · Pain · 2004 · 69 citations
Life Sciences, Cell Biology, Pharmacology +17
Δ9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain
Thomas H. Burkey, Raymond M. Quock, Paul Consroe et al. · European Journal of Pharmacology · 1997 · 62 citations
Life Sciences, Neuroscience, Pharmacology +13
1–5 of 15